HOMELAND SECURITY NEWS WIRE – The development of a medication to treat illness from Ebola will be accelerated under a contract with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). HHS says that this contract supports the government-wide response to the Ebola outbreak in West Africa. The $24.9 million, 18-month contract with Mapp Biopharmaceutical Inc., of San Diego, California, may be extended up to a total of $42.3 million. BARDA notes that it is seeking additional proposals for the advanced development of antibody treatments, antiviral drugs, and vaccines against the Ebola and Marburg viruses Continue